Ulcerative Colitis Clinical Trial
MAC Clinical Research are currently conducting a trial to test a potential new treatment for moderate to severe ulcerative colitis (UC).
Improving quality of life
Register Your Interest
What Happens Next?
About this Ulcerative Colitis Clinical Trial
MAC Clinical Research are currently conducting a clinical trial to test a potential new treatment for ulcerative colitis (UC). UC is a chronic inflammatory disease of the rectal & colonic mucosa which is characterised by periods of remission and relapse, or ‘flare-ups’. Autoimmune and inflammatory diseases such as UC can happen when a person’s immune system becomes unbalanced.
The investigational medicine, is a monoclonal antibody (antibodies that act like human antibodies in your immune system) that may reduce inflammation associated with ulcerative colitis.
– Male or female aged 18 and over
– Diagnosis of ulcerative colitis, as confirmed by a GP or specialist
– Active ulcerative colitis – currently passing at least some blood during bowel movements
– An inadequate response or intolerance to at least one previous UC treatment (additional criteria may apply), OR currently receiving oral corticosteroids, Azathioprine, or 6-mercaptopurine for the treatment of UC (minimum dose levels will apply)
Eligible patients will receive a health screen and study participation will be in collaboration with your treating physician.